Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001415889-25-010880

VP, Pharmaceutical Development acquired 13,350 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cappello Joseph VP, Pharmaceutical Development 2025-03-14 Grant or award +13,350 57,003 D
Loading xslF345X05/form4-04172025_080429.xml…